Electrophysiology-Based Assays to Detect Subtype-Selective Modulation of Human Nicotinic Acetylcholine Receptors

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• The Family Smoking Prevention and Tobacco Control Act of 2009 mandates FDA regulation of tobacco products.
• Nicotine, the primary addictive component of tobacco, exerts its effects by interacting with neuronal nicotinic acetylcholine receptors (nAChRs).
• Understanding the subtype-selective actions of tobacco constituents on nAChRs is critical for assessing the physiological impact of tobacco products.

Purpose of the Study:

• To develop and validate electrophysiology-based high-throughput screens (e-HTS) for key human nAChR subtypes.
• To enable efficient profiling of the subtype-selective effects of tobacco constituents and other compounds on nAChRs.

Main Methods:

• Development and validation of e-HTS assays for human nAChR subtypes (α3β4, α3β4α5, α4β2, and α7) expressed in Chinese Hamster Ovary cells.
• Comparison of e-HTS results with conventional manual patch clamp electrophysiology for agonist sensitivity, acute desensitization, antagonist potency, and positive allosteric modulator selectivity.
• Pilot screening of FDA-approved drugs using the developed e-HTS assays.

Main Results:

• Electrophysiology-based high-throughput screens demonstrated comparable results to manual patch clamp assays for agonist sensitivity and desensitization.
• The potency of reference antagonists and selectivity of positive allosteric modulators were consistent between e-HTS and conventional methods.
• Pilot screening identified α7 subtype-selective positive allosteric modulation by novel compounds among FDA-approved drugs.

Conclusions:

• The developed e-HTS assays provide reliable and efficient tools for assessing nicotinic acetylcholine receptor subtype selectivity.
• These assays are valuable for characterizing the pharmacological profiles of tobacco constituents and potential therapeutic agents.
• The validated e-HTS platform facilitates a deeper understanding of the mechanisms underlying tobacco product addiction and harm.